July 07, 2022

Login to your account

Username *
Password *
Remember Me

Create an account

Fields marked with an asterisk (*) are required.
Name *
Username *
Password *
Verify password *
Email *
Verify email *
Captcha *
Reload Captcha

All Articles


By Renaissance Capital,

Bausch + Lomb, a leading supplier of contact lenses and eyecare products, announced terms for its IPO on Thursday. The company plans to dual list on the Toronto Stock Exchange.

The Vaughan, Canada-based company plans to raise $788 million by offering 35 million shares (100% secondary) at a price range of $21 to $24. At the midpoint of the proposed range, Bausch + Lomb would command a fully diluted market value of $8.2 billion.

Bausch + Lomb states that it is a leading global eye health company, with global brand awareness of more than 70%. The company has a presence in approximately 100 countries and a comprehensive portfolio of over 400 products, and it is fully integrated to serve its customers...

By Khyathi Dalal, 
  • ClimateRock (CLRC) priced its 7.5M units IPO at an offer price of $10/unit; each unit consists of one Class A ordinary share, one-half of...

IPO Initial Public Offering
By Val Kennedy, 



Novovirus vaccine developer HilleVax (HLVX) has upsized its initial public offering to $175M from $100M.

The biotech...

Read Also

© 2021 Disruptive Fare @ DisruptiveFare.com a production of Crediblock.com LLC

Please publish modules in offcanvas position.